LEXINGTON, Mass. --(BUSINESS WIRE)--Nov. 7, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate at the following upcoming investor conferences: The Stifel 2018 Healthcare Conference on November 14, 2018 , at 2:00 p.m.
Findings Presented at American College of Toxicology 2018 Annual Meeting LEXINGTON, Mass. --(BUSINESS WIRE)--Nov. 5, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented preclinical results that support the potential of CTP-692, the Company’s novel drug candidate for schizophrenia,
Conference Call Scheduled Today at 8:30 a.m. ET LEXINGTON, Mass. --(BUSINESS WIRE)--Nov. 1, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2018. “This is an exciting time at Concert as we advance multiple pipeline candidates, with our
LEXINGTON, Mass. --(BUSINESS WIRE)--Oct. 25, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2018 financial results on Thursday, November 1, 2018 , before the U.S. financial markets open. The Company will host a conference call and webcast
Company On Track to Report Topline Data from the 4 mg and 8 mg Twice-Daily Cohorts in Fourth Quarter of 2018 LEXINGTON, Mass. --(BUSINESS WIRE)--Sep. 26, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will include an additional cohort of patients in the Phase 2a trial
LEXINGTON, Mass. --(BUSINESS WIRE)--Aug. 29, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences: The Wells Fargo Securities 2018 Healthcare Conference on September 5, 2018 at 10:15 a.m.
LEXINGTON, Mass. --(BUSINESS WIRE)--Jul. 26, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2018 financial results on Thursday, August 2, 2018 , before the U.S. financial markets open. The Company will host a conference call and webcast at
Conference Call Scheduled Today at 8:30 a.m. EDT LEXINGTON, Mass. --(BUSINESS WIRE)--May 3, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2018. “Concert has begun 2018 with strong momentum as our pipeline of first-in-class drug
LEXINGTON, Mass. --(BUSINESS WIRE)--Apr. 26, 2018-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its first quarter 2018 financial results on Thursday, May 3, 2018 , before the U.S. financial markets open. The Company will host a conference call and webcast at
